Skip to content
Lower risk Medical device recall · FDA · Published November 1, 2019

Bio-Rad BioPlex 2200 ANA Screen Control Set Incompatible with Older Reagents

Bio-Rad recalls BioPlex 2200 ANA Screen Control Sets (REF: 663-1131) that are incompatible with older ANA reagent packs and calibrators. Affected units may cause inaccurate test results.

🇺🇸 FDA recall #Z-0082-2022Medical deviceBio-Rad ›
Take action

Contact the company

Recalling firmBio-Rad Laboratories, Inc.6565 185th Ave Ne · Redmond, WA 98052-5039
✎ GovInfoNow plain-language explainer

Bio-Rad is recalling BioPlex 2200 ANA Screen Control Sets that don't work with older reagent packs and calibrators. This could lead to inaccurate test results if used with incompatible products. Read more at govinfonow.com/recall/66583-bio-rad-bioplex-2200-ana-screen-control-set-incompatible-with.

Source Summary by GovInfoNow · govinfonow.com/recall/66583-bio-rad-bioplex-2200-ana-screen-control-set-incompatible-with · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0082-2022

Cite this page

“Bio-Rad BioPlex 2200 ANA Screen Control Set Incompatible with Older Reagents.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/66583-bio-rad-bioplex-2200-ana-screen-control-set-incompatible-with. Based on FDA recall #Z-0082-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0082-2022%22&limit=1).

The FDA announced on 2019-11-01 that Bio-Rad Laboratories, Inc. is recalling its BioPlex 2200 ANA Screen Control Set due to incompatibility with certain older ANA calibrators and reagent packs. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Bio-Rad
  • Product: BioPlex 2200 ANA Screen Control Set, REF: 663-1131
  • Lot: 51765, Expiration: 03/05/2021
  • Incompatible with REF: 665-1150, Lot-Expiration: 300884-11/30/2019, 300907-1/31/2020, 300928-3/31/2020, 300933-4/30/2020
  • Incompatible with REF: 663-1101, Lot-Expiration: 50661-11/30/2019, 50726-3/11/2020, 50835-3/27/2020, 50858-5/1/2020

The hazard

A new lot of ANA screen control and any subsequent control lots are incompatible with older lot numbers of ANA calibrators and ANA reagent packs, according to the FDA.

Context

GovInfoNow's records show Bio-Rad Laboratories, Inc. has 12 other recalls on record since 2018-04-02. Other recent recalls include a 2025-05-30 recall of the Bio-Rad Platelia Toxo IgM Kit due to false positive risks and a 2023-02-28 recall of the Bio-Rad BioPlex 220 for incorrect reagent packaging.

How to tell if you have this one

Check for BioPlex 2200 ANA Screen Control Sets with reference number 663-1131, lot number 51765 or later. Also look for older reagent packs (REF: 665-1150) and calibrators (REF: 663-1101) with specific expiration dates listed in the recall.

  • Brand
    Bio-Rad
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Compatibility

    Verify if your BioPlex 2200 ANA Screen Control Set (REF: 663-1131) is compatible with your reagent packs and calibrators by checking the lot numbers and expiration dates.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 41 states.

Alaska: named in the noticeAKMaine: named in the noticeMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: nationwideCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide distribution - U.S Nationwide distribution including in the states of CA, FL, NJ, IL, NE, TN, IN, TX, LA, WA, MI, MA, MN, OH, HI, MO, PA, CT, UT, SD, NY, AL, PR, OR, MD, KY, NC, AZ, SC, VA, WI, GA, IA, RI, AK, OK, KS, ND, MS, ME,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Connecticut, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin.

Recall timeline

FDA terminated this recall 3.9 years after the firm started it.

1. Firm started the recall: Nov 1, 201912. FDA classified it Class II: Oct 8, 202123. Published in FDA’s Enforcement Report: Oct 20, 202134. FDA terminated the recall: Sep 27, 2023420192023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0082-2022 (November 1, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0082-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA